Loftus Peak Pty Ltd’s AstraZeneca AZN Stock Holding History

Loftus Peak Pty Ltd’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.6M	Buy	+102,629	New	+$17.1M	2.12%	21

Other funds holding AZN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Oslo Pensjonsforsikring Oslo $863M AUM 18.29% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Loftus Peak Pty Ltd's AZN Position: Q3 2026 in Review

Loftus Peak Pty Ltd opened a new position in AstraZeneca (AZN) in Q3 2026: 102,629 shares worth $16.6M. The stake represents 2.12% of the portfolio and ranks #21 among its holdings.

172 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Loftus Peak Pty Ltd held 102,629 shares of AstraZeneca worth $16.6M as of Q3 2026.
AstraZeneca was a new Loftus Peak Pty Ltd position in Q3 2026.
AstraZeneca made up 2.12% of Loftus Peak Pty Ltd's portfolio in Q3 2026, its #21 holding.
172 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Loftus Peak Pty Ltd's 13F filing for Q3 2026, filed 15 Oct 2026.